DARA BioSciences (DARA) Releases Quarterly Earnings, Beats Expectations By $0.27 EPS
DARA BioSciences (NASDAQ:DARA) issued its quarterly earnings data on Tuesday. The company reported ($0.24) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.51) by $0.27, AnalystRatingsNetwork.com reports.
DARA BioSciences (NASDAQ:DARA) remained flat at $1.32 during trading on Tuesday. 347,611 shares of the company’s stock traded hands. DARA BioSciences has a 1-year low of $1.02 and a 1-year high of $4.40. The stock’s 50-day moving average is $1.29 and its 200-day moving average is $2.04. The company’s market cap is $11.1 million.
DARA BioSciences, Inc (NASDAQ:DARA) is a development-stage pharmaceutical company that acquires therapeutic drug candidates for development and licensing or sale to healthcare companies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.